Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Preferred Stock Liabilities (2017 - 2021)

Historic Preferred Stock Liabilities for Cogent Biosciences (COGT) over the last 4 years, with Q3 2021 value amounting to $85.4 million.

  • Cogent Biosciences' Preferred Stock Liabilities fell 3821.98% to $85.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $85.4 million, marking a year-over-year decrease of 3821.98%. This contributed to the annual value of $110.9 million for FY2020, which is N/A changed from last year.
  • Cogent Biosciences' Preferred Stock Liabilities amounted to $85.4 million in Q3 2021, which was down 3821.98% from $85.4 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Preferred Stock Liabilities registered a high of $138.2 million during Q3 2020, and its lowest value of $77.2 million during Q4 2017.
  • Its 4-year average for Preferred Stock Liabilities is $95.6 million, with a median of $85.4 million in 2021.
  • Data for Cogent Biosciences' Preferred Stock Liabilities shows a peak YoY increase of 3821.98% (in 2021) and a maximum YoY decrease of 3821.98% (in 2021) over the last 5 years.
  • Quarter analysis of 4 years shows Cogent Biosciences' Preferred Stock Liabilities stood at $77.2 million in 2017, then grew by 0.02% to $77.2 million in 2018, then surged by 43.69% to $110.9 million in 2020, then dropped by 22.98% to $85.4 million in 2021.
  • Its Preferred Stock Liabilities stands at $85.4 million for Q3 2021, versus $85.4 million for Q2 2021 and $94.7 million for Q1 2021.